James Schaub Biography and Net Worth



James Schaub has served as our Executive Vice President and Chief Operating Officer since 2016. Mr. Schaub previously served as Chief Operating Officer of Trigen Laboratories and as Vice President of M&A at Fougera Pharmaceuticals, Inc. He also held several commercial roles of increasing responsibility at King Pharmaceuticals, Inc. Mr. Schaub is a graduate of Middlebury College and holds an M.B.A. from Rutgers Business School.

How do I contact James Schaub?

The corporate mailing address for Mr. Schaub and other Osmotica Pharmaceuticals executives is 400 CROSSING BOULEVARD, BRIDGEWATER NJ, 08807. Osmotica Pharmaceuticals can also be reached via phone at (908) 809-1300 and via email at [email protected]. Learn More on James Schaub's contact information.

Has James Schaub been buying or selling shares of Osmotica Pharmaceuticals?

James Schaub has not been actively trading shares of Osmotica Pharmaceuticals within the last three months. Most recently, on Thursday, December 16th, James Schaub bought 93,800 shares of Osmotica Pharmaceuticals stock. The stock was acquired at an average cost of $1.07 per share, with a total value of $100,366.00. Learn More on James Schaub's trading history.

James Schaub Insider Trading History at Osmotica Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/16/2021Buy93,800$1.07$100,366.00View SEC Filing Icon  
See Full Table

James Schaub Buying and Selling Activity at Osmotica Pharmaceuticals

This chart shows James Schaub's buying and selling at Osmotica Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Osmotica Pharmaceuticals Company Overview

Osmotica Pharmaceuticals logo
Osmotica Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $1.16
Low: $0.98
High: $1.49

2 Week Range

Now: N/A

Volume

296,500 shs

Average Volume

396,682 shs

Market Capitalization

$69.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.34